Pulmatrix Inc - PULM Earnings per share for the trailing year

Pulmatrix Corporation (PULM) - corporate logo

Pulmatrix, Inc. (PULM) relies on its unique iSPERSE system for pulmonary drug delivery, monetizing patents through strategic partnerships. This chart from GURU.Markets showing the annual change in EPS (TTM) confirms profit dynamics, where 48.80 determines this parameter level. Consistent R&D in antifungal agents is balanced by raw material supply chain risks and geopolitical barriers.

pulmatrix.com (PULM): Earnings per share for the last twelve months from 02/11/2024 to 11/14/2026

Financial and market metric breakdowns for Pulmatrix Corp (PULM)

- stock price and consensus target price:
Price pulmatrix.com|PULM - Analyst Consensus Forecast
- issuer market value details:
Market Value Pulmatrix Inc|PULM - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Pulmatrix|PULM - Company Book Value|Market Value to Book Value pulmatrix.com|PULM - Aggregate Company Assets
- company total debt and liquidity indicators:
Aggregate Debt to Equity Pulmatrix, Inc.|PULM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Pulmatrix Corporation|PULM - Company Debts|Debt to Book Capitalization Ratio Pulmatrix Inc|PULM - Company Long-Term Debt|Company Current Liabilities Pulmatrix|Quick Ratio pulmatrix.com
- net income and valuation ratios data:
PULM - Net Income|Future Net Profit Pulmatrix, Inc.|PULM - Price to Earnings Ratio|Future Price to Earnings Multiple Pulmatrix Inc|PULM - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Pulmatrix Inc|PULM - Operating profit before deduction of amortization|Earnings per share for the last 12 months Pulmatrix|PULM - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months pulmatrix.com|PULM - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Pulmatrix, Inc.
- revenue and sales details:
PULM - Company Revenue|Company Revenue Forecast pulmatrix.com|PULM - P/S Multiple|Forward Price-to-Revenue Multiple Pulmatrix Inc
Initial company analysis:pulmatrix.com - PULM
Brand item of Pulmatrix Corp

The effectiveness of Pulmatrix, Inc. (PULM) in protecting its iSPERSE intellectual moat for treating pulmonary pathologies is reflected through the measurement of annual EPS TTM growth. This indicator compares net earnings per share over the last four quarters with the same period last year, allowing investors to identify stagnation or acceleration in business capitalization rates, which is critical for assessing startup maturity under FDA regulatory pressure.

Competitor analysis

haleon.com - Earnings per share for the last four quarters|KVUE: Net earnings per share (EPS TTM)|Verona Pharma PLC - Earnings per share for the trailing year|MENS (Jyong Biotech Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ligand Corp LGND|Earnings per share for the last twelve months Amneal Pharmaceuticals (AMRX)|PRGO (perrigo.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Alvotech SA ALVO|LQDA (Liquidia Corp) - Earnings per one share for the last 12 months|GLPG: Net earnings per share for the last 12 months|ANIP - Net earnings per share (EPS TTM)|MannKind Corporation (MNKD) - Earnings per share for the last twelve months|AMPH (amphastar.com) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Pacira BioSciences, Inc.|Net earnings per share for the last 12 months ARS Pharmaceuticals Inc (SPRY)|Net earnings per share (EPS TTM) TBPH|Net earnings per share (EPS TTM) Aquestive Corp (AQST)|scPharmaceuticals - Net earnings per share for the last 12 months|Earnings per share for the last four quarters TECX (Tectonic Therapeutic Inc.)|TNXP - Earnings per share for the last twelve months|Earnings per share for the trailing year SXTC (China SXT Pharmaceuticals)|EPRX: Net earnings per share (EPS TTM)|BHST - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months EXOZ|Earnings per share for the last 12 months ORMP (Oramed Pharma)|Net earnings per share for the last 12 months ENTX (Entera Bio Ltd.)|HYFT (MindWalk Holdings, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC (ABVC BioPharma Inc)|Net earnings per share for the last four quarters Cumberland Corp (CPIX)|QNTM - Earnings per share for the last twelve months|FGEN (fibrogen.com) - Earnings per share for the last 12 months|TELO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Rani Therapeutics Holdings, Inc.|Net earnings per share for the last 12 months SNYR|Rallybio Corp. (RLYB) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Lexaria Bioscience (LEXX)|PTHL: Earnings per one share for the last 12 months|Aptorum Group - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Lyra Therapeutics Inc. LYRA|IBO - Earnings per share for the last twelve months|TNFA: Earnings per share for the last twelve months|cbdmd.com (YCBD) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months painreform.com|Earnings per share for the last twelve months Altamira Therapeutics Ltd|Lipella Pharmaceuticals Inc - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) OPTN|PIRS (Pieris Pharma) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PROC (Procaps Group S.A.)|Net earnings per share (EPS TTM) petrospharma.com PTPI|QLI - Earnings per share for the last twelve months|Earnings per share for the trailing year SLRN (Acelyrin Inc.)|TFF Pharma (TFFP) - Earnings per share for the last twelve months